Massachusetts · Bill 1222 · 194th General Court

An Act relative to prescription medication re-authorization

  1. Introduced Feb 27, 2025
  2. In committee Feb 27, 2025
  3. Passed the House Next
  4. Passed the Senate  
  5. To the governor  
  6. Became law  

What it does

The legislature's own summary of the bill, or its official long title.

By Representative Kerans of Danvers, a petition (accompanied by bill, House, No. 1222) of Sally P. Kerans relative to prohibiting insurers from requiring annual re-authorizations for certain prescription drugs. Financial Services.

Every action

7 steps, oldest first, as the legislature records them.

  1. CommitteeReferred to the committee on Financial Services · Joint Committee on Financial Services
  2. SenateSenate concurred
  3. CommitteeHearing scheduled for 06/10/2025 from 10:30 AM-01:00 PM in A-2 · Joint Committee on Financial Services
  4. CommitteeReported favorably by committee and referred to the committee on Health Care Financing · Joint Committee on Health Care Financing
  5. HouseReporting date extended to Wednesday, March 18, 2026
  6. HouseReporting date extended to Monday, June 15, 2026
  7. HouseReporting date extended to Friday, July 31, 2026

Roll calls

1 recorded vote: 0 on the floor, 1 in committee. Each shows how every member voted.

Committee votes

DateWhereQuestionResult
Sep 8, 2025 Joint Committee on Financial Services Committee report: Favorable (Favorable report on pharmacy matters)
Members

Yes · 11

11–0

Sponsors

The member who introduced it.

From Massachusetts's official records (malegislature.gov/api), checked Nov 19, 2026. Text links go to the official versions; LegiList does not copy bill text.